# A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk

> **NCT00586469** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1000 (actual)

## Conditions studied

- Influenza Vaccines

## Interventions

- **BIOLOGICAL:** Fluviral

## Key facts

- **NCT ID:** NCT00586469
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-14
- **Primary completion:** 2008-01-14
- **Final completion:** 2008-01-14
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2019-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586469, "A Randomized Study to Compare the Safety and Immunogenicity of Fluviral® Made With New Versus Aged Bulk". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00586469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*